Loading stock data…
$21.20-0.07 (-0.33%)
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong.
Prenetics Global Limited in the Consumer Defensive sector is trading at $21.27 with a market capitalization of $430M. Wall Street consensus targets $38.12 (8 analysts), implying a +79.2% move over the next 12 months. The stock is currently 22% below its 52-week high of $27.24, remaining 9.4% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $46.49M↑ | $35.95M↓ | $36.56M↑ | $23.55M↑ | $11.96M |
| Gross Profit | $30.20M↑ | $23.28M↑ | $21.59M↑ | $14.02M↑ | $7.37M |
| Operating Income | -$21.92M↓ | -$9.71M↑ | -$13.14M↓ | -$6.56M↑ | -$8.38M |
| Net Income | -$8.98M↑ | -$23.10M↓ | -$7.50M↓ | -$7.41M↑ | -$12.41M |
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer g...